FOLH1 and prostate carcinoma: Results of the meta-analysis by Ferrari et al. confirmed that 18F-PSMA-1007 PET/CT demonstrated a good detection rate in biochemical recurrent prostate cancer (81.3%) and higher PSA values were associated with higher DR [38].